Showing results (591-600 of 1,018) with videos related to
Sort By:
Pageof 102
Cancer Research Communications|January 20, 2025
MYC and HSF1 Cooperate to Drive Sensitivity to Polo-like Kinase 1 Inhibitor Volasertib in High-grade Serous Ovarian CancerImade Williams, Matthew O'Malley, Haddie DeHart, et al.Cancer Research Communications|December 6, 2024
Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 PathwayMizuho Nakayama, Hiroshi Saito, Kazuhiro Murakami, et al.Cancer Research Communications|December 3, 2024
Efficacy of CBP/p300 Dual Inhibitors against Derepression of KREMEN2 in cBAF-Deficient CancersMariko Sasaki, Daiki Kato, Hiroshi Yoshida, et al.Cancer Research Communications|September 3, 2024
NCI's Proteomic Data Commons: A Cloud-Based Proteomics Repository Empowering Comprehensive Cancer Analysis through Cross-Referencing with Genomic and Imaging DataRatna R Thangudu, Michael Holck, Deepak Singhal, et al.Cancer Research Communications|September 3, 2024
MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse ModelAlexandra Blackman, Amy C Rees, Robert R Bowers, et al.Cancer Research Communications|August 29, 2024
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder CancerMatthew T Campbell, Amishi Y Shah, Pavlos Msaouel, et al.Cancer Research Communications|August 29, 2024
Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow ScreenThomas Drabison, Mike Boeckman, Yan Yang, et al.Cancer Research Communications|November 27, 2024
Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced ImmunosuppressionMalcolm F McDonald, Rachel Naomi Curry, Isabella O'Reilly, et al.Cancer Research Communications|July 15, 2024
Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid SynthesisGretchen M Alicea, Payal Patel, Marie E Portuallo, et al.Cancer Research Communications|July 18, 2024
Exploring Disparities in Pancreatic Ductal Adenocarcinoma Outcomes among Asian and Pacific Islander SubgroupsChristopher Wu, M Chandler McLeod, Zhixing Song, et al.Pageof 102